Expected USE
The COVID-19 Antigen Rapid Test Kit is a solitary use gadget. It is a
sidelong stream immunoassay which distinguishes SARS-CoV-2 antigen, the infection
that causes COVID-19, in oropharyngeal swab, nasal swab, and
nasopharyngeal swab tests. The presence of such antigen shows
potential COVID-19 disease.
Rundown
Results are for the discovery of SARS-CoV-2 antigen. SARS-CoV-2
antigens are by and large discernible a few days after starting disease. The
levels of antigen will be higher during early contamination, and decline as the
contamination advances. The test is best utilized when side effects, if any,
show up.
Positive outcomes are demonstrative of intense or late disease.
Adverse outcomes don’t block COVID-19 disease and shouldn’t be
utilized as the sole reason for patient administration choices.
For research utilize as it were.
Foundation
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
is a new infection liable for the respiratory ailment Coronavirus
Illness 2019 (COVID-19). First reported in the city of Wuhan(China), it has spread to most nations across the globe.
The first wellspring of SARS-CoV-2 is obscure. It has been accounted for tohave high likeness to Covids viewed as in bats and pangolins,
in any case, neither of these creatures are remembered to have been sold in the meat market that the earliest patients visited, proposing and middle of the road have.
The infection is effortlessly communicated from one individual to another, basically through
beads.
Tainted people can lessen transmission rates by wearing
a facial covering or covering the mouth while hacking/sniffling, by cleaning their hands consistently, and by holing up. Individuals who have not yet been tainted can wear a facial covering and use eye security to
block beads, not touch their face or food without cleaning first, and stay away from swarmed regions.
The death rate for COVID-19 has been challenging to work out due to the
number of undiscovered cases. Gauges range from 0.02% to 14%;
generally focus at around 2-4%. The danger to the normal solid
grown-up is low, but immunodeficiencies or respiratory ailments can
increment the mortality risk considerably.
TEST PRINCIPLE
The Abbexa COVID-19 Antigen Rapid Test Kit is a parallel stream immunoassay which can recognize SARS-CoV-2/COVID-19 infection antigen.
The example cushion inside the tape contains gold nanoparticles covered with hostile to SARS-CoV-2 neutralizer and mouse IgG. Hostile to SARS-CoV-2
immune response is covered in the individual test district on a nitrocellulose film, making the test line, and Goat hostile to Mouse IgG antibodies are covered on the control line. The control district on the upper finish of
the tape affirms assuming the test has been fruitful. The test accompanies a tape, swab, and extraction support tube. When a right volume of test and cushion is administered into the example
well of the test tape, the example relocates by slender activity along
the test strip.
On the off chance that there is any SARS-CoV-2 infection antigen in the example,
it will tie to the SARS-CoV-2 immunizer forms. The
immunocomplex will then be caught by the SARS-CoV-2 immunizer in
the test line, shaping a purple-shaded T Line, demonstrating a SARS-CoV2 infection antigen positive experimental outcome.
Data in regards to the invulnerable reaction to SARS-CoV-2 is restricted
despite everything advancing. As of now, it is obscure the way in which long the antigen may
persevere following disease.
The test contains an interior control (C Line) which shows a purplecolored band of goat hostile to mouse IgG/mouse IgG-gold form
immunocomplex no matter what the variety advancement on any of the test
groups (T Line). Assuming no control band is noticed, the experimental outcome is invalid
furthermore, the example should be retested.
REAGENTS AND MATERIALS
The pack is given in a 25 test size. The quantity of parts are as
Organization
Form Pad Gold nanoparticles covered with SARS-CoV-2
immune response, and mouse IgG.
T Line SARS-CoV-2 immune response.
C Line Goat polyclonal immune response to mouse IgG.
Other Material Required But Not Provided
Clock
Capacity AND STABILITY
1. Store the cushion and tape at 2-30°C (36-86°F). These parts
are steady for at least a year.
3. Whenever put away at 2-8˚C, guarantee that the test gadget is brought to 15-25˚C.
Test COLLECTION AND PREPARATION
Consider any materials of human beginning as irresistible and handle utilizing
the suitable standard biosafety systems. The World Health Association as of now suggests testing tests possibly conveying the SARS-CoV-2 infection in Biosafety Level 2 offices.
Oropharyngeal Swab: Tilt the head back and open the mouth wide, uncovering the pharyngeal tonsils on the two sides. Utilize the swab to tenderly
wipe the tonsils on the two sides something like multiple times every, then wipe the
back pharyngeal divider (the mouth rooftop over the tonsils) somewhere around 3 times.
Nasal Swab: Prior to gathering the example, the patient ought to blow their nose. Cautiously embed the swab into the nostril and push until opposition is met (short of what one inch into the nostril), pivot the swab against the
nasal divider a few times and afterward eliminate it from the nostril. Nasopharyngeal swab: Carefully embed the swab into the nostril, keep the swab close to the floor of the nasal cavity while delicately pushing the swab
into the back nasopharynx (back of the throat). Turn the swab a few times then eliminate it tenderly.
QUALITY CONTROL
Interior Control: This test contains an inherent control include, the C Line.
The C Line creates after expansion of the Extraction Buffer. In the event that the C Line
doesn’t create, the test is invalid. Audit the strategy and rehash
the test with another gadget..
1. Substantial Assay
The readout ought to show 1 line in the C (control) district. A line may
show up close to the T area relying upon the presence of SARS-CoV2 antigen. Faint lines are treated as a positive outcome.
1.1 C and T districts are positive: patient has intense or late contamination
with SARS-CoV-2.
1.2 C area positive, T district negative: patient doesn’t have intense
contamination with SARS-CoV-2.
2. Invalid Assay
C area negative, T locale either certain or negative: test didn’t
work accurately.
Adverse outcomes don’t preclude SARS-CoV-2 contamination, especially for
patients who have been in touch with known tainted people or in
regions with high commonness of dynamic disease. Follow-up testing with a
sub-atomic analytic test is important to preclude contamination in these
people.
Results from neutralizer testing ought not be utilized as the sole premise to
analyze or avoid SARS-CoV-2 disease.
Misleading positive outcomes might happen because of cross-responding antigens from
different diseases, for example, other Covids, or from different causes.
Execution CHARACTERISTICS
1. Clinical Performance
1.1 Study of: Testing of RT-PCR positive clinical examples
31 (31) positive swab tests gathered from people who
tried positive with a RT-PCR technique for SARS-CoV-2 contamination. These
tests, alongside one hundred and 27 (127) negative swab
tests were coded and tried along with the abx294181 COVID19 Antigen Rapid Test Kit.
COVID-19 Antigen Rapid Test |
|||
ICOV-802H | Hangzhou AllTest Biotech | 25 Tests | 12.5 EUR |
GA COVID-19 Rapid Antigen Test |
|||
BSV-3980 | BioServUK | 20 tests | 500 EUR |
COVID-19 Antigen Rapid Test Pen (Saliva) |
|||
BSV-COV-2PEN20 | BioServUK | 20 pc | 177 EUR |
Rapid Response COVID-19 Saliva Rapid Antigen Test |
|||
BSV-COV-2C25B | BioServUK | 25 tests | 316 EUR |
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-20tests | Accu test | 20 tests | 283.2 EUR |
Healgen Rapid COVID-19 Antigen Self-Test |
|||
BSV-GCCOV-502a-H1-10 | BioServUK | 10 | Ask for price |
Healgen Rapid COVID-19 Antigen Self-Test |
|||
BSV-GCCOV-502a-H1-1000 | BioServUK | 1000 | Ask for price |
Healgen Rapid COVID-19 Antigen Self-Test |
|||
BSV-GCCOV-502a-H1-200 | BioServUK | 200 | Ask for price |
COVID-19 IgG/IgM Rapid Test Kit |
|||
UNCOV-20 | UnScience | 20T/kit | 186 EUR |
COVID-19 Ag Rapid Test, Cs |
|||
R0182C | CTK Biotech | 20 | 1.25 EUR |
COVID-19 IgG.IgM Rapid Test, Cs |
|||
R0180C | CTK Biotech | 30 | 0.9 EUR |
COVID-19 Panbio™ COVID-19 Ag Rapid Test Device |
|||
AF41FK10CFE | Abbott | 25T | 220 EUR |
COVID-19 Ag Rapid Test External Control Kit |
|||
C0182 | CTK Biotech | each | 520 EUR |
COVID-19 IgG/IgM Rapid Test Development Kit |
|||
MBS2563888-500Tests | MyBiosource | 500Tests | 500 EUR |
COVID-19 IgG/IgM Rapid Test Development Kit |
|||
MBS2563888-5x500Tests | MyBiosource | 5x500Tests | 2225 EUR |
Innovita COVID-19 IgG/IgM Rapid Test |
|||
BSV-RAPID-02 | BioServUK | 40 tests | 1011 EUR |
Brucella Antigen Rapid Test Kit |
|||
abx092116-100l | Abbexa | 100 µl | 350 EUR |
Brucella Antigen Rapid Test Kit |
|||
abx092116-1ml | Abbexa | 1 ml | Ask for price |
Brucella Antigen Rapid Test Kit |
|||
abx092116-200l | Abbexa | 200 µl | Ask for price |
Of the 31 PCR positive examples, 28 (28) tried positive with abx294181. Of the 127 PCR negative examples,
one hundred and 26 (126) tried negative with abx294181.
Taken together, the abx294181 COVID-19 Antigen Rapid Test Kit had
a responsiveness and particularity of 90.32% and 99.21%, separately.